Zhen-Gang Yuan - AI Profile | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 39 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Comprehensive Genomic Profiling in Solid Tumors: Enhancing Treatment Selection and Prognosis

Minghui Wang,Yanhong Shang,Zhen-gang Yuan, Qing Hao,Zhizheng Wang,Dong You, Yang Liu,Fei Pang,Wei Rao,Yinying Wu,Leilei Lu

Journal of Clinical Oncologyno. 16_suppl (2024): e13631-e13631

引用0浏览0引用

Bortezomib in Previously Treated Phosphatase and Tension Homology‐deficient Patients with Advanced Intrahepatic Cholangiocarcinoma: an Open‐label, Prospective and Single‐centre Phase II Trial

Tian-mei Zeng,Tian-yi Jiang,Guang Yang,Zhuo Cheng,Cheng Lou, Wei,Chen-jie Tao,Shouzi Hu,Hui Wang,Xiao-wen Cui,Ye-xiong Tan,Li-wei Dong,Hong-yang Wang,Zhen-gang Yuan

CLINICAL AND TRANSLATIONAL MEDICINEno. 5 (2024)

引用0浏览0WOS引用

The Pattern of Tumor Progression on First-Line Immune Checkpoint Inhibitor-Based Systemic Therapy for Chinese Advanced Hepatocellular Carcinoma –CLEAP 004 Study

Chao-Xu Yang,Yang-Xun Pan, Feng Ye,Xiao-Dong Zhu,Jun Xue, Xi Li,Zhen-Gang Yuan,Lan Zhang,Li Xu,Yong-Jun Chen,Nan-Ya Wang,Hui-Chuan Sun,Xiu-Feng Liu

FRONTIERS IN IMMUNOLOGY（2024）

引用0浏览0WOS引用

Efficacy and Predictors of Immune Checkpoint Inhibitors in Patients with Gallbladder Cancer

Zhuo Cheng, Cheng Yang,Qian Zhao, Jingjiao Zhong,Jin Zhang,Riming Jin, Yao Li,Na Ta,Dong Wu,Zhengang Yuan,Wen Sun,Ruoyu Wang

Journal of Clinical Oncologyno. 16_suppl (2023): e16124-e16124

引用0浏览0WOS引用

Clinical and Biomarker Analyses of Sintilimab Plus Gemcitabine and Cisplatin As First-Line Treatment for Patients with Advanced Biliary Tract Cancer

Tian-mei Zeng,Guang Yang,Cheng Lou, Wei,Chen-jie Tao,Xi-yun Chen,Qin Han,Zhuo Cheng,Pei-pei Shang,Yu-long Dong,He-ming Xu,Lie-ping Guo,Dong-sheng Chen,Yun-jie Song,Chuang Qi,Wang-long Deng,Zhen-gang Yuan

Nature communicationsno. 1 (2023): 1340-1340

引用2浏览0WOSNATURE引用

基于网络药理学探讨通关藤抗肝细胞癌的作用机制

董雨龙,娄成,陈熙昀, 魏炜,陶晨洁, 韩琴,袁振刚

Journal of Pharmaceutical and Serviceno. 10 (2023)

引用0浏览0引用

首次疗效评估中肿瘤最长径之和变化对晚期肝内胆管癌化疗患者生存预后的预测价值

董雨龙,陶晨洁,娄成,陈熙昀, 魏炜, 韩琴,袁振刚

Journal of Tongji University(Medical Science)no. 5 (2023)

引用0浏览0引用

Expert Consensus on Pathological Diagnosis of Intrahepatic Cholangiocarcinoma (2022 Version)

Journal of clinical and translational hepatologyno. 7 (2023): 1553-1564

引用3浏览0WOS引用

Toripalimab Combined with Anlotinib As the Second-Line Treatment for Advanced Hepatocellular Carcinoma Patients: a Prospective, Single Arm Phase II Clinical Study

Wei,Xiyun Chen,Tianmei Zeng,Guang Yang,Yulong Dong,Chenjie Tao, Qin Han,Cheng Lou,Peipei Shang,Zhuo Cheng,Weipeng Hong,Yuange He, Weidong Shen,Zhengang Yuan,Lieping Guo

crossref（2023）

引用0浏览0引用

Genomic and Immune Features in an Intrahepatic Cholangiocarcinoma Patient with Microsatellite Instability-High Suffered Rapid Acquired Resistance to PD-1 Inhibitor

Zhuo Cheng,Tianmei Zeng,Guang Yang, Di Liu, Zhi Zheng,Zhengang Yuan

Liver cancerno. 3 (2023): 281-288

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn